Total Voting Rights

RNS Number : 1180I
Circassia Pharmaceuticals Plc
31 March 2020
 

For immediate release

 

Circassia Pharmaceuticals plc

 

Total Voting Rights Update

 

 

 

31st March 2020

 

In accordance with the requirements of the FCA's Disclosure and Transparency Rule 5.6.1, Circassia Pharmaceuticals plc ("Circassia" or "the Company") (LSE: CIR) confirms that the Company's issued share capital consists of   375,210,543 ordinary shares of 0.08p each in issue, each with equal voting rights.  No shares are held in treasury. 

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules .

 

-Ends-

 

For further information, please contact:

 

Circassia Pharmaceuticals plc

Michael Roller, Company Secretary

 

+44 (0) 1865 405560

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVREAKDEDEXEEFA

Companies

Niox Group (NIOX)
UK 100

Latest directors dealings